Human IFIT1 inhibits mRNA translation of rubulaviruses but not other members of the Paramyxoviridae family

Journal of Virology

Volumn 90, Issue 20, 2016, Pages 9446-9456

  Young, D F ^a   Andrejeva, J ^a   Li, X ^b   Inesta Vaquera, F ^c   Dong, C ^b   Cowling, V H ^c   Goodbourn, S ^d   Randall, R E ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIS ACTING ELEMENT; MESSENGER RNA; PROTEIN IFIT1; RIBOSE; UNCLASSIFIED DRUG; VIRUS RNA; ALPHA INTERFERON; CAPPED RNA; CARRIER PROTEIN; IFIT1 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CANINE DISTEMPER VIRUS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN PARAINFLUENZA VIRUS 2; HUMAN PARAINFLUENZA VIRUS 3; HUMAN PARAINFLUENZA VIRUS 5; IN VITRO STUDY; METHYLATION; MIXED INFECTION; MUMPS VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; RUBULAVIRUS; SENDAI VIRUS; TRANSLATION REGULATION; VIRUS TRANSCRIPTION; A-549 CELL LINE; GENETICS; HUMAN; METABOLISM; PARAINFLUENZA VIRUS 5; PARAMYXOVIRIDAE; PROTEIN SYNTHESIS; TUMOR CELL LINE; VIRUS REPLICATION;

A549 CELLS; CARRIER PROTEINS; CELL LINE, TUMOR; HUMANS; INTERFERON-ALPHA; METHYLATION; MUMPS VIRUS; PARAINFLUENZA VIRUS 5; PARAMYXOVIRIDAE; PROTEIN BIOSYNTHESIS; RNA CAPS; RNA, MESSENGER; RNA, VIRAL; RUBULAVIRUS; SENDAI VIRUS; VIRUS REPLICATION;

EID: 84990026732     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01056-16     Document Type: Article

References (58)

1. Samal SK. 2011. The biology of paramyxoviruses. Caister Academic Press, Wymondham, England.
2. Lamb RA, Parks GD. 2013. Paramyxoviridae. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed (electronic). Lippincott Williams & Wilkins, Philadelphia, PA.
3. Parks GD, Alexander-Miller MA. 2013. Paramyxovirus activation and inhibition of innate immune responses. J Mol Biol 425:4872-4892. http://dx.doi.org/10.1016/j.jmb.2013.09.015.
4. Goodbourn S, Randall RE. 2009. The regulation of type I interferon production by paramyxoviruses. J Interferon Cytokine Res 29:539-547. http://dx.doi.org/10.1089/jir.2009.0071.
5. Ramachandran A, Horvath CM. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J Interferon Cytokine Res 29:531-537. http://dx.doi.org/10.1089/jir.2009.0070.
6. Fontana JM, Bankamp B, Rota PA. 2008. Inhibition of interferon induction and signaling by paramyxoviruses. Immunol Rev 225:46-67. http://dx.doi.org/10.1111/j.1600-065X.2008.00669.x.
7. Audsley MD, Moseley GW. 2013. Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol 2:57-70. http://dx.doi.org/10.5501/wjv.v2.i2.57.
8. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
9. Broz P, Monack DM. 2013. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 13:551-565 http://dx.doi.org/10.1038/nri3479.
10. Schmidt A, Endres S, Rothenfusser S. 2011. Pattern recognition of viral nucleic acids by RIG-I-like helicases. J Mol Med (Berl) 89:5-12. http://dx.doi.org/10.1007/s00109-010-0672-8.
11. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol 1:519-525. http://dx.doi.org/10.1016/j.coviro.2011.10.008.
12. Sun D, Luthra P, Li Z, He B. 2009. PLK1 down-regulates parainfluenza virus 5 gene expression. PLoS Pathog 5:e1000525. http://dx.doi.org/10.1371/journal.ppat.1000525.
13. Dillon PJ, Parks GD. 2007. Role for the phosphoprotein p subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. J Virol 81:11116-11127. http://dx.doi.org/10.1128/JVI.01360-07.
14. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111. http://dx.doi.org/10.1016/j.virol.2006.03.022.
15. Killip MJ, Young DF, Gatherer D, Ross CS, Short JA, Davison AJ, Goodbourn S, Randall RE. 2013. Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction. J Virol 87:4798-4807. http://dx.doi.org/10.1128/JVI.03383-12.
16. Tapia K, Kim WK, Sun Y, Mercado-Lopez X, Dunay E, Wise M, Adu M, Lopez CB. 2013. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog 9:e1003703. http://dx.doi.org/10.1371/journal.ppat.1003703.
17. Lopez CB. 2014. Defective viral genomes: critical danger signals of viral infections. J Virol 88:8720-8723. http://dx.doi.org/10.1128/JVI.00707-14.
18. Carlos TS, Young DF, Schneider M, Simas JP, Randall RE. 2009. Parainfluenza virus 5 genomes are located in viral cytoplasmic bodies whilst the virus dismantles the interferon-induced antiviral state of cells. J Gen Virol 90:2147-2156. http://dx.doi.org/10.1099/vir.0.012047-0.
19. Young DF, Andrejeva L, Livingstone A, Goodbourn S, Lamb RA, Collins PL, Elliott RM, Randall RE. 2003. Virus replication in engineered human cells that do not respond to interferons. J Virol 77:2174-2181. http://dx.doi.org/10.1128/JVI.77.3.2174-2181.2003.
20. Schoenborn JR, Wilson CB. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41-101. http://dx.doi.org/10.1016/S0065-2776(07)96002-2.
21. Fensterl V, Sen GC. 2015. Interferon-induced Ifit proteins: their role in viral pathogenesis. J Virol 89:2462-2468. http://dx.doi.org/10.1128/JVI.02744-14.
22. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472:481-485. http://dx.doi.org/10.1038/nature09907.
23. Andrejeva J, Norsted H, Habjan M, Thiel V, Goodbourn S, Randall RE. 2013. ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis. J Gen Virol 94:59-68. http://dx.doi.org/10.1099/vir.0.046797-0.
24. Kumar P, Sweeney TR, Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. 2014. Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'-terminal regions of cap0-, cap1-and 5'ppp-mRNAs. Nucleic Acids Res 42:3228-3245. http://dx.doi.org/10.1093/nar/gkt1321.
25. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M, Jr, Shi PY, Diamond MS. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456. http://dx.doi.org/10.1038/nature09489.
26. Hyde JL, Diamond MS. 2015. Innate immune restriction and antagonism of viral RNA lacking 2-O methylation. Virology 479-480:66-74. http://dx.doi.org/10.1016/j.virol.2015.01.019.
27. Vladimer GI, Gorna MW, Superti-Furga G. 2014. IFITs: emerging roles as key anti-viral proteins. Front Immunol 5:94. http://dx.doi.org/10.3389/fimmu.2014.00094.
28. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR, Burckstummer T, Stefanovic A, Krieger S, Bennett KL, Rulicke T, Weber F, Colinge J, Muller M, Superti-Furga G. 2011. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol 12: 624-630. http://dx.doi.org/10.1038/ni.2048.
29. Fensterl V, Sen GC. 2011. The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31:71-78. http://dx.doi.org/10.1089/jir.2010.0101.
30. Daugherty MD, Schaller AM, Geballe AP, Malik HS. 2016. Evolutionguided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. Elife 5:e14228. http://dx.doi.org/10.7554/eLife.14228.
31. Leung DW, Amarasinghe GK. 2016. When your cap matters: structural insights into self vs non-self recognition of 5' RNA by immunomodulatory host proteins. Curr Opin Struct Biol 36:133-141. http://dx.doi.org/10.1016/j.sbi.2016.02.001.
32. Durbin AP, McAuliffe JM, Collins PL, Murphy BR. 1999. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. Virology 261:319-330. http://dx.doi.org/10.1006/viro.1999.9878.
33. Choppin PW. 1964. Multiplication of a myxovirus (Sv5) with minimal cytopathic effects and without interference. Virology 23:224-233. http://dx.doi.org/10.1016/0042-6822(64)90286-7.
34. Chen C, Compans RW, Choppin PW. 1971. Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities. J Gen Virol 11:53-58. http://dx.doi.org/10.1099/0022-1317-11-1-53.
35. Enders JF, Levens JH, Stokes J, Jun Maris EP, Berenberg W. 1946. Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg. J Immunol 54:283-291.
36. Collins PL, Murphy BR. 2002. Respiratory syncytial virus: reverse genetics and vaccine strategies. Virology 296:204-211. http://dx.doi.org/10.1006/viro.2002.1437.
37. Chen S, Short JA, Young DF, Killip MJ, Schneider M, Goodbourn S, Randall RE. 2010. Heterocellular induction of interferon by negativesense RNA viruses. Virology 407:247-255. http://dx.doi.org/10.1016/j.virol.2010.08.008.
38. Randall RE, Dinwoodie N. 1986. Intranuclear localization of herpes simplex virus immediate-early and delayed-early proteins: evidence that ICP 4 is associated with progeny virus DNA. J Gen Virol 67(Part 10):2163-2177.
39. Randall RE, Young DF, Goswami KK, Russell WC. 1987. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J Gen Virol 68(Part 11):2769-2780.
40. Rydbeck R, Love A, Orvell C, Norrby E. 1987. Antigenic analysis of human and bovine parainfluenza virus type 3 strains with monoclonal antibodies. J Gen Virol 68(Part 8):2153-2160.
41. Leppert M, Rittenhouse L, Perrault J, Summers DF, Kolakofsky D. 1979 Plus and minus strand leader RNAs in negative strand virus-infected cells. Cell 18:735-747. http://dx.doi.org/10.1016/0092-8674(79)90127-2.
42. Gonatopoulos-Pournatzis T, Dunn S, Bounds R, Cowling VH. 2011. RAM/Fam103a1 is required formRNAcap methylation. Mol Cell 44:585-596 http://dx.doi.org/10.1016/j.molcel.2011.08.041.
43. Hilton L, Moganeradj K, Zhang G, Chen YH, Randall RE, McCauley JW, Goodbourn S. 2006. The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation. J Virol 80:11723-11732. http://dx.doi.org/10.1128/JVI.01145-06.
44. Young DF, Galiano MC, Lemon K, Chen YH, Andrejeva J, Duprex WP, Rima BK, Randall RE. 2009. Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist. J Gen Virol 90:2731-2738. http://dx.doi.org/10.1099/vir.0.013722-0.
45. Chatziandreou N, Young D, Andrejeva J, Goodbourn S, Randall RE. 2002 Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293:234-242. http://dx.doi.org/10.1006/viro.2001.1302.
46. Habjan M, Hubel P, Lacerda L, Benda C, Holze C, Eberl CH, Mann A, Kindler E, Gil-Cruz C, Ziebuhr J, Thiel V, Pichlmair A. 2013. Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. PLoS Pathog 9:e1003663. http://dx.doi.org/10.1371/journal.ppat.1003663.
47. Abbas YM, Pichlmair A, Gorna MW, Superti-Furga G, Nagar B. 2013. Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature 494:60-64. http://dx.doi.org/10.1038/nature11783.
48. Rahmeh AA, Li J, Kranzusch PJ, Whelan SP. 2009. Ribose 2'-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein. J Virol 83:11043-11050. http://dx.doi.org/10.1128/JVI.01426-09.
49. Abraham N, Stojdl DF, Duncan PI, Methot N, Ishii T, Dube M, Vanderhyden BC, Atkins HL, Gray DA, McBurney MW, Koromilas AE, Brown EG, Sonenberg N, Bell JC. 1999. Characterization of transgenic mice with targeted disruption of the catalytic domain of the doublestranded RNA-dependent protein kinase, PKR. J Biol Chem 274:5953-5962 http://dx.doi.org/10.1074/jbc.274.9.5953.
50. Hyde JL, Gardner CL, Kimura T, White JP, Liu G, Trobaugh DW, Huang C, Tonelli M, Paessler S, Takeda K, Klimstra WB, Amarasinghe GK, Diamond MS. 2014. A viral RNA structural element alters host recognition of nonself RNA. Science 343:783-787. http://dx.doi.org/10.1126/science.1248465.
51. Kimura T, Katoh H, Kayama H, Saiga H, Okuyama M, Okamoto T, Umemoto E, Matsuura Y, Yamamoto M, Takeda K. 2013. Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. J Virol 87:9997-10003. http://dx.doi.org/10.1128/JVI.00883-13.
52. Menachery VD, Yount BL, Jr, Josset L, Gralinski LE, Scobey T, Agnihothram S, Katze MG, Baric RS. 2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-omethyltransferase activity. J Virol 88:4251-4264. http://dx.doi.org/10.1128/JVI.03571-13.
53. Szretter KJ, Daniels BP, Cho H, Gainey MD, Yokoyama WM, Gale M, Jr, Virgin HW, Klein RS, Sen GC, Diamond MS. 2012. 2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and-independent mechanisms of host restriction in vivo. PLoS Pathog 8:e1002698. http://dx.doi.org/10.1371/journal.ppat.1002698.
54. Zhang Y, Wei Y, Zhang X, Cai H, Niewiesk S, Li J. 2014. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase. J Virol 88:11411-11429. http://dx.doi.org/10.1128/JVI.00876-14.
55. Murphy AM, Moerdyk-Schauwecker M, Mushegian A, Grdzelishvili VZ. 2010. Sequence-function analysis of the Sendai virus L protein domain VI. Virology 405:370-382. http://dx.doi.org/10.1016/j.virol.2010.06.019.
56. Pinto AK, Williams GD, Szretter KJ, White JP, Proenca-Modena JL, Liu G, Olejnik J, Brien JD, Ebihara H, Muhlberger E, Amarasinghe G, Diamond MS, Boon AC. 2015. Human and murine IFIT1 proteins do not restrict infection of negative-sense RNA viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae families. J Virol 89:9465-9476. http://dx.doi.org/10.1128/JVI.00996-15.
57. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. 2011. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85:12881-12889. http://dx.doi.org/10.1128/JVI.05633-11.
58. Precious BL, Carlos TS, Goodbourn S, Randall RE. 2007. Catalytic turnover of STAT1 allows PIV5 to dismantle the interferon-induced antiviral state of cells. Virology 368:114-121. http://dx.doi.org/10.1016/j.virol.2007.06.024.